menu
    • menu

    Company profile for Mersana Therapeutics

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Mersana is a biopharmaceutical company specializing in the discovery and development of antibody-drug conjugate (ADC) therapies to treat patients fighting cancer. Leveraging decades of industry learnings, we have developed proprietary and highly differentiated ADC platforms and expertise to rapidly design and test novel ADCs and identify those with optimal efficacy, safety and tolerability.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Mersana TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    Mersana Therapeutics 840 Memorial Drive Cambridge, MA 02139
    Telephone
    Telephone
    617.498.0020
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.mersana.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/mersana-therapeutics
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/@MersanaADC

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Mersana Pharma Updates Business & Reveals Q3 2025 Financials
    Mersana Pharma Updates Business & Reveals Q3 2025 Financials

    14 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/14/3188201/0/en/Mersana-Therapeutics-Provides-Business-Update-and-Announces-Third-Quarter-2025-Financial-Results.html

    GLOBENEWSWIRE
    14 Nov 2025
    Share Share
    Day One Biopharmaceuticals To Acquire Mersana Therapeutics
    Day One Biopharmaceuticals To Acquire Mersana Therapeutics

    13 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/13/3187105/0/en/Day-One-Biopharmaceuticals-to-Acquire-Mersana-Therapeutics.html

    GLOBENEWSWIRE
    13 Nov 2025
    Share Share
    Mersana Therapeutics Hosts Q3 2025 Conference Call On Nov 14
    Mersana Therapeutics Hosts Q3 2025 Conference Call On Nov 14

    10 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/10/3184470/0/en/Mersana-Therapeutics-to-Host-Third-Quarter-2025-Conference-Call-on-November-14-2025.html

    GLOBENEWSWIRE
    10 Nov 2025
    Share Share
    Mersana Therapeutics Q2 2025 Results and Business Update
    Mersana Therapeutics Q2 2025 Results and Business Update

    13 Aug 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/08/13/3132438/0/en/Mersana-Therapeutics-Provides-Business-Update-and-Announces-Second-Quarter-2025-Financial-Results.html

    GLOBENEWSWIRE
    13 Aug 2025
    Share Share
    Mersana Therapeutics schedules Q2 2025 Conference Call
    Mersana Therapeutics schedules Q2 2025 Conference Call

    06 Aug 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/08/06/3128279/0/en/Mersana-Therapeutics-to-Host-Second-Quarter-2025-Conference-Call-on-August-13-2025.html

    GLOBENEWSWIRE
    06 Aug 2025
    Share Share
    Mersana Therapeutics Initiates 1-for-25 Reverse Stock Split
    Mersana Therapeutics Initiates 1-for-25 Reverse Stock Split

    24 Jul 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/07/24/3121081/0/en/Mersana-Therapeutics-Announces-1-for-25-Reverse-Stock-Split.html

    GLOBENEWSWIRE
    24 Jul 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search